Literature DB >> 15471856

Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation.

Susana G Santos1, Simon J Powis, Fernando A Arosa.   

Abstract

Knowledge of the origin and biochemical status of beta(2)-microglobulin-free or misfolded major histocompatibility complex (MHC)-I molecules is essential for understanding their pleiotropic properties. Here we show that in normal human T cells, misfolding of MHC-I molecules is turned on upon activation and cell division and is proportional to the level of proliferation. Immunoprecipitation showed that a number of proteins are associated with MHC-I heavy chains at the surface of activated T cells, including the CD8alphabeta receptor and the chaperone tandem calreticulin/ERp57, associations that rely upon the existence of a pool of HC-10-reactive molecules. Biochemical analysis showed that misfolded MHC-I molecules present at the cell surface are fully glycosylated mature molecules. Importantly, misfolded MHC-I molecules are tyrosine phosphorylated and are associated with kinase activity. In vitro kinase assays followed by reprecipitation indicated that tyrosine phosphorylation of the class I heavy chain is probably mediated by a Src tyrosine kinase because Lck was found associated with HC-10 immunocomplexes. Finally, we show that inhibition of tyrosine phosphorylation by using the Src-family tyrosine kinase inhibitor PP2 resulted in enhanced release of MHC-I heavy chains from the cell surface of activated T cells and a slight down-regulation of cell surface W6/32-reactive molecules. This study provides new insights into the biology of MHC-I molecules and suggests that tyrosine phosphorylation may be involved in the regulation of MHC-I misfolding and expression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471856     DOI: 10.1074/jbc.M408794200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

2.  MHC molecules lead many lives. Workshop on MHC Class I Molecules at the interface between Biology & Medicine.

Authors:  Paul Bowness; Steve Caplan; Michael Edidin
Journal:  EMBO Rep       Date:  2008-12-05       Impact factor: 8.807

3.  HLA-F complex without peptide binds to MHC class I protein in the open conformer form.

Authors:  Jodie P Goodridge; Aura Burian; Ni Lee; Daniel E Geraghty
Journal:  J Immunol       Date:  2010-05-05       Impact factor: 5.422

4.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.

Authors:  C Andrew Stewart; Fanny Laugier-Anfossi; Frédéric Vély; Xavier Saulquin; Jenifer Riedmuller; Agnès Tisserant; Laurent Gauthier; François Romagné; Géraldine Ferracci; Fernando A Arosa; Alessandro Moretta; Peter D Sun; Sophie Ugolini; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

5.  Characterization of signaling function and expression of HLA class I molecules in medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Elisabeth J Rushing; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Neurooncol       Date:  2010-09-02       Impact factor: 4.130

6.  DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells.

Authors:  Kinga K Hosszu; Alisa Valentino; Uma Vinayagasundaram; Rama Vinayagasundaram; M Gordon Joyce; Yan Ji; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

7.  MHCI negatively regulates synapse density during the establishment of cortical connections.

Authors:  Marian W Glynn; Bradford M Elmer; Paula A Garay; Xiao-Bo Liu; Leigh A Needleman; Faten El-Sabeawy; A Kimberley McAllister
Journal:  Nat Neurosci       Date:  2011-02-27       Impact factor: 24.884

8.  Major histocompatibility complex class I molecules modulate embryonic neuritogenesis and neuronal polarization.

Authors:  Tina Bilousova; Hoa Dang; Willem Xu; Sarah Gustafson; Yingli Jin; Lalinda Wickramasinghe; Tony Won; Gabriela Bobarnac; Blake Middleton; Jide Tian; Daniel L Kaufman
Journal:  J Neuroimmunol       Date:  2012-04-12       Impact factor: 3.478

9.  BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.

Authors:  Sherille D Bradley; Zeming Chen; Brenda Melendez; Amjad Talukder; Jahan S Khalili; Tania Rodriguez-Cruz; Shujuan Liu; Mayra Whittington; Wanleng Deng; Fenge Li; Chantale Bernatchez; Laszlo G Radvanyi; Michael A Davies; Patrick Hwu; Gregory Lizée
Journal:  Cancer Immunol Res       Date:  2015-03-20       Impact factor: 11.151

10.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.